+281.7%
NVDA vs THC
+428.0%
-146.3%
-36.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.3% | +2.0% | -6.3% | -4.5% |
| 7D | -11.6% | +7.5% | -19.1% | -12.4% |
| 30D | -22.1% | +9.6% | -31.6% | -23.0% |
| 3M | -20.1% | +10.3% | -30.4% | -21.2% |
| 6M | -16.8% | +51.8% | -68.6% | -22.0% |
| YTD | -4.0% | +45.4% | -49.4% | -9.8% |
| 1Y | -4.8% | +40.8% | -45.6% | -10.3% |
| 3Y | +281.7% | +448.8% | -167.1% | +202.6% |
| All | +281.7% | +428.0% | -146.3% | +202.6% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling